Global Breast Cancer Imaging and Screening Market Set to Explode as Cancer Rates Increase
Nikhil Prasad Fact checked by:Thailand Medical News Team Apr 13, 2025 1 day, 8 hours, 8 minutes ago
Thailand Medical Devices:
Surging Demand for Breast Cancer Detection Spurs Billion Dollar Industry Boom
Breast cancer continues to be a pressing health crisis for women across the globe. With over 2.3 million women diagnosed and more than 685,000 deaths reported in 2020 alone, the world is now seeing an urgent push for earlier and more accurate diagnosis methods. This rising health burden is now paving the way for a multibillion-dollar global industry—breast imaging technologies.
Global Breast Cancer Imaging and Screening Market Set to Explode as Cancer Rates Increase
The global breast imaging market, valued at USD 4.75 billion in 2024, is projected to skyrocket to nearly USD 8.03 billion by the year 2032. This represents a steady compound annual growth rate (CAGR) of 6.79% over the forecast period from 2025 to 2032.
https://www.maximizemarketresearch.com/market-report/global-breast-imaging-market/21004/
Much of this expected growth is driven by a combination of increasing awareness around early breast cancer detection and the rapid development of advanced diagnostic tools.
This
Thailand Medical Devices News report dives deep into the key market forces, technologies, regional trends, and major players transforming breast cancer screening into one of the fastest-growing segments in the healthcare sector.
Why Early Detection Is More Critical Than Ever
Breast cancer is now the most commonly diagnosed cancer in women worldwide, surpassing lung cancer in many regions. Its rising prevalence is alarming public health authorities and driving more women to seek early diagnostic screenings like mammograms and ultrasounds.
The World Health Organization and other agencies stress that early detection significantly increases survival rates. For instance, regular mammograms can reduce breast cancer mortality by up to 33% in women aged 60–69 and by 14% in those aged 50–59. With such compelling statistics, governments, hospitals, and healthcare institutions are increasing efforts to expand screening access and encourage routine testing, especially in high-risk populations.
What’s more, patient demand is also shifting. Women are no longer just seeking diagnosis—they want fast, comfortable, and radiation-free imaging options. This is where technological innovation steps in.
Technology Reshaping the Future of Breast Imaging
The breast imaging sector is now riding the wave of cutting-edge medical advancements. Technologies once confined to experimental labs are becoming mainstream. These include both ionizing and non-ionizing imaging tools that offer better resolution, higher detection accuracy, and reduced discomfort during screening.
Ionizing Breast Imaging Technologies: These tools use low doses
of radiation to capture detailed breast tissue images:
-
Full-Field Digital Mammography (FFDM) and 3D Breast Tomosynthesis are widely used for early detection
-
PET/CT and Molecular Breast Imaging (MBI) provide functional imaging that reveals how tissues and organs are working
-
Positron Emission Mammography (PEM) allows for high-resolution imaging, particularly useful in dense breast tissue cases
Non-Ionizing Technologies: For those concerned about radiation, non-ionizing methods are quickly gaining popularity:
-
Breast Ultrasound and Automated Whole-Breast Ultrasound (AWBU) are commonly used for additional imaging, especially in women with dense breasts
-
Breast MRI provides extremely detailed imaging, especially useful in high-risk patients or complex cases
-
Breast Thermography, though less common, is gaining attention for its ability to detect heat patterns and blood flow associated with tumors
One major game changer is the integration of Artificial Intelligence (AI). AI algorithms are now being trained to scan mammograms faster and more accurately than ever before. In the UK, the National Health Service (NHS) is already trialing AI to analyze nearly 700,000 mammograms. If successful, this could redefine breast cancer screening protocols globally.
New FDA Approvals Fuel Innovation
In October 2021, the U.S. Food and Drug Administration gave premarket approval to the SoftVue 3D whole breast ultrasound tomography system developed by Delphinus Medical Technologies. This radiation-free imaging method is specifically designed to improve cancer detection in women with dense breast tissue—a group that traditional mammography often fails to serve effectively.
Such approvals are pushing companies to accelerate development pipelines and bring more comfortable, accurate, and affordable imaging options to market.
Hospitals Diagnostic Centers and Surgical Clinics Drive Usage
Breast imaging technologies are now being integrated across several types of healthcare facilities:
-
Hospitals remain the largest segment. Equipped with the latest imaging infrastructure and skilled radiologists, hospitals serve both outpatient screenings and diagnostic evaluations.
-
Diagnostic Imaging Centers are often focused entirely on radiological services and are becoming increasingly popular due to shorter wait times and specialized breast imaging services.
-
Ambulatory Surgical Centers (ASCs) are incorporating imaging systems to facilitate minor procedures, biopsies, and immediate diagnostics.
Each of these settings plays a vital role in increasing access to timely and effective breast cancer screening.
Global Demand Surges Across Major Regions
United States: With over 280,000 new cases of invasive breast cancer diagnosed annually, the U.S. remains the largest market for breast imaging technologies. Federal and private insurers are backing nationwide screening programs, and tech companies are heavily investing in diagnostic tools.
-
Germany: A well-funded healthcare system and strong focus on preventive care have made Germany a major adopter of advanced imaging systems. The country’s national breast cancer screening program is among the most comprehensive in Europe.
-
China: With rising income levels, better healthcare infrastructure, and government awareness campaigns, China’s breast imaging market is rapidly expanding. Urban centers are particularly witnessing a surge in screening volumes.
-
United Kingdom: The UK is leading in AI integration, with major NHS trials underway to evaluate machine learning in mammogram analysis. This has set a precedent for AI-driven diagnosis worldwide.
-
India: Though adoption is slower, India is catching up. Awareness drives, subsidized screening, and corporate wellness initiatives are helping increase imaging access among urban and semi-urban populations.
Top Companies Dominating the Market
A number of powerful global players are shaping this rapidly growing industry:
Hologic Inc. leads with a wide range of 3D mammography solutions, constantly pushing R&D to improve imaging quality and reduce scan times.
-
Siemens Healthineers is investing heavily in AI integration to automate workflows and improve diagnostic accuracy.
-
GE Healthcare provides everything from traditional mammograms to AI-enhanced imaging platforms and is expanding rapidly into emerging markets.
-
Philips Healthcare focuses on patient comfort, offering next-generation ultrasound and mammography systems.
Conclusion
The global breast imaging market is undergoing a revolutionary transformation. As more women worldwide become aware of the importance of early breast cancer detection, demand for advanced diagnostic technologies is reaching unprecedented levels. Innovations in AI, the introduction of non-invasive imaging techniques, and growing investment from both the public and private sectors are creating a robust framework for market expansion.
While affordability and access still pose challenges in many regions, particularly in low- and middle-income countries, the increasing focus on women’s health, government-backed screening programs, and patient education are helping bridge the gap. Hospitals, imaging centers, and tech firms alike are doubling efforts to make screenings more comfortable, more accurate, and more accessible than ever before. As the battle against breast cancer intensifies, breast imaging technologies are not only saving lives but also redefining how healthcare approaches early cancer detection. The next decade is expected to bring even more dramatic advances as this critical sector continues to grow and evolve.
For the latest
Thailand Medical Devices news report, keep on logging to Thailand Medical News.
Read Also:
https://www.thailandmedical.news/news/thailand-doctors-and-radiologists-find-that-siemens-and-neusoft-ct-scanners-outperform-philips-ct-machines
https://www.thailandmedical.news/news/breaking-medical-devices-news-some-philips-mri-machines-have-risk-of-exploding-u-s-fda-initiates-class-one-recall
https://www.thailandmedical.news/news/medical-devices-new-airtouch-portable-x-ray-gets-us-fda-approval,-convenient-for-covid-19-diagnosis
https://www.thailandmedical.news/pages/thailand_doctors_listings
https://www.thailandmedical.news/pages/thailand_hospital_listings
Share
Tweet
Share
